VIFELZAN
DEAD

Serial Number

79316939

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jun 15, 2021

Add to watchlist:

No watchlists yet
View on USPTO

VIFELZAN Trademark

Serial Number: 79316939 • Registration: 6709116

VIFELZAN is a trademark filed by NOVARTIS AG on June 15, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

June 15, 2021

Registration Date

April 26, 2022

Published for Opposition

February 8, 2022

Cancellation Date

October 22, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
May 22, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
May 22, 2025 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 20, 2022 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Sep 1, 2022 FICS
FINAL DISPOSITION PROCESSED
Sep 1, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 26, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 26, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 8, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 19, 2022 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 28, 2021 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 15, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 14, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 13, 2021 TROA
REFUSAL PROCESSED BY IB
Nov 23, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 24, 2021 RFCS
REFUSAL PROCESSED BY MPU
Oct 21, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 29, 2021 RFCR
NON-FINAL ACTION WRITTEN
Sep 28, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 28, 2021 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 15, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 15, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 15, 2021 COAR
APPLICATION FILING RECEIPT MAILED
Aug 14, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 10, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 9, 2021 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 29, 2021 SDRC